The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers

Gastrointestinal cancers (GICs) occupy more than 30% of the cancer-related incidence and mortality around the world. Despite advances in the treatment strategies, the long-term overall survival has not been improved for patients with GICs. Recently, the novel patient-derived organoid (PDO) culture t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ya-ya, Zhu, Yan-juan, Xiao, Zhen-zhen, Chen, Ya-dong, Chang, Xue-song, Liu, Yi-hong, Tang, Qing, Zhang, Hai-bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547471/
https://www.ncbi.nlm.nih.gov/pubmed/36207749
http://dx.doi.org/10.1186/s40364-022-00421-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547471/
https://www.ncbi.nlm.nih.gov/pubmed/36207749
http://dx.doi.org/10.1186/s40364-022-00421-0

Ejemplares similares